Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) major shareholder L1 Capital Pty Ltd sold 251,844 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $9.10, for a total transaction of $2,291,780.40. Following the sale, the insider directly owned 5,187,156 shares of the company’s stock, valued at approximately $47,203,119.60. This trade represents a 4.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
L1 Capital Pty Ltd also recently made the following trade(s):
- On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total transaction of $3,495,079.50.
- On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total transaction of $1,415,240.10.
- On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total transaction of $3,989,046.40.
- On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.23, for a total value of $120,001.63.
- On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total value of $3,853,113.30.
- On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.15, for a total value of $396,994.65.
- On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.04, for a total value of $1,250,260.20.
- On Thursday, July 30th, L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.20, for a total value of $4,580,790.60.
- On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.19, for a total value of $1,906,771.23.
- On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.09, for a total value of $1,688,633.79.
Anteris Technologies Global Trading Up 2.3%
Shares of NASDAQ AVR opened at $9.17 on Wednesday. The company has a market cap of $892.61 million, a price-to-earnings ratio of -4.11 and a beta of 1.78. Anteris Technologies Global Corp. has a 12 month low of $3.17 and a 12 month high of $11.06. The stock has a 50-day moving average price of $9.15 and a two-hundred day moving average price of $7.33.
Institutional Investors Weigh In On Anteris Technologies Global
Institutional investors have recently added to or reduced their stakes in the business. Militia Capital Management LLC acquired a new position in shares of Anteris Technologies Global during the first quarter worth $3,358,000. Avidity Partners Management LP acquired a new stake in Anteris Technologies Global in the first quarter valued at $832,000. SummitTX Capital L.P. acquired a new stake in Anteris Technologies Global in the first quarter valued at $1,326,000. Perceptive Advisors LLC lifted its holdings in Anteris Technologies Global by 104.4% during the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock worth $19,011,000 after buying an additional 1,750,000 shares during the period. Finally, Assenagon Asset Management S.A. bought a new stake in shares of Anteris Technologies Global in the 2nd quarter valued at about $6,350,000.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on AVR shares. Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Barclays increased their price target on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Anteris Technologies Global presently has an average rating of “Moderate Buy” and a consensus target price of $16.00.
View Our Latest Stock Analysis on Anteris Technologies Global
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Recommended Stories
- Five stocks we like better than Anteris Technologies Global
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
